← 返回

CC 趋化因子受体是胃癌的预后指标,并与免疫浸润相关

英文原题:CC chemokine receptors are prognostic indicators of gastric cancer and are associated with immune infiltration.

查看英文原题

CC chemokine receptors are prognostic indicators of gastric cancer and are associated with immune infiltration.

PubMed 2024/01/02(内容时间) BMC Med Genomics Q2 · IF 2.6(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

研究概要

我们的研究确定 CC 趋化因子受体的表达有助于预测诊断为 GC 的患者的预后。CC 趋化因子受体的表达水平也与多种 TIL(肿瘤浸润淋巴细胞)(TILs)呈正相关。这些发现为使用 CC 趋化因子受体监测 GC 患者提供了证据,CC 趋化因子受体可作为预测疾病预后的有效生物标志物,并被视为调节肿瘤免疫微环境的治疗靶点。

研究思路结论见上方概要

CC 趋化因子受体负责调节肿瘤微环境(TME),并参与癌变和肿瘤进展。然而,尚无功能研究探讨 CC 趋化因子受体在胃癌(GC)预后、风险、免疫治疗或其他治疗中的作用。

我们对GC数据进行了生物信息学分析,使用了在线数据库,包括人类蛋白质图谱(HPA)、Kaplan-Meier(KM)绘图仪、GeneMANIA、MethSurv、阿拉巴马大学伯明翰分校癌症(UALCAN)数据分析门户、基因集癌症分析(GSCA)、cBioportal和肿瘤免疫估计资源(TIMER)。

我们注意到CC趋化因子受体的表达与GC的生存率相关。CC趋化因子受体的表达也与不同的肿瘤浸润免疫细胞密切相关。此外,发现CC趋化因子受体在GC中普遍具有耐药性。

展开英文摘要原文

CC chemokine receptors are responsible for regulating the tumor microenvironment (TME) and participating in carcinogenesis and tumor advancement. However, no functional study has investigated CC chemokine receptors in gastric cancer (GC) prognosis, risk, immunotherapy, or other treatments.

We conducted a bioinformatics analysis on GC data using online databases, including the Human Protein Atlas (HPA), Kaplan-Meier (KM) plotter, GeneMANIA, MethSurv, the University of ALabama at Birmingham CANcer (UALCAN) Data Analysis Portal, Gene Set Cancer Analysis (GSCA), cBioportal, and Tumor IMmune Estimation Resource (TIMER).

We noted that CC chemokine receptor expression correlated with survival in GC. CC chemokine receptor expression was also strongly linked to different tumor-infiltrating immune cells. Additionally, CC chemokine receptors were found to be broadly drug-resistant in GC.

Our study identifed CC chemokine receptor expression helped in predicting the prognosis of patients diagnosed with GC. The expression level of the CC chemokine receptors was also positively related to multiple tumor-infiltrating lymphocytes (TILs). These findings provide evidence to monitor patients with GC using CC chemokine receptors, which can be used as an effective biomarker for predicting the disease prognosis and be regarded as a therapeutic target for modulating the tumor immune microenvironment.

论文信息

作者
Liao X、Yang Y、Wang L、Kong Z、Li W
第一作者单位
Department of Integrated Therapy, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.China
通讯作者单位
Department of Gastrointestinal Surgery, the First people's Hospital of Taicang City, Taicang Affiliated Hospital of Soochow University, Taicang City, 215400, Jiangsu Province, China. question12397@163.com.China
期刊
BMC medical genomics2024 Jan 2
原文标识
PubMed 38169378 · DOI 10.1186/s12920-023-01690-w